W. Keller‐Schierlein

4.7k total citations
136 papers, 3.5k citations indexed

About

W. Keller‐Schierlein is a scholar working on Pharmacology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, W. Keller‐Schierlein has authored 136 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Pharmacology, 67 papers in Molecular Biology and 52 papers in Organic Chemistry. Recurrent topics in W. Keller‐Schierlein's work include Microbial Natural Products and Biosynthesis (70 papers), Steroid Chemistry and Biochemistry (24 papers) and Synthetic Organic Chemistry Methods (23 papers). W. Keller‐Schierlein is often cited by papers focused on Microbial Natural Products and Biosynthesis (70 papers), Steroid Chemistry and Biochemistry (24 papers) and Synthetic Organic Chemistry Methods (23 papers). W. Keller‐Schierlein collaborates with scholars based in Germany, Switzerland and Italy. W. Keller‐Schierlein's co-authors include Hans Zähner, V. Prelog, H. Z�hner, M. Brufani, L. Neipp, Hans‐Peter Kaiser, L. Ettlinger, E. Gäumann, R. Hütter and H Zähner and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Bacteriology and Cellular and Molecular Life Sciences.

In The Last Decade

W. Keller‐Schierlein

135 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Keller‐Schierlein Germany 34 1.6k 1.4k 1.3k 492 387 136 3.5k
NOBORU OTAKE Japan 31 1.8k 1.1× 1.3k 1.0× 1.4k 1.1× 365 0.7× 372 1.0× 224 3.4k
Petr Sedmera Czechia 32 1.9k 1.2× 1.0k 0.7× 1.6k 1.2× 604 1.2× 360 0.9× 273 4.1k
D. Arigoni Germany 40 4.6k 2.8× 1.2k 0.9× 1.3k 1.0× 769 1.6× 362 0.9× 152 6.4k
Carsten Christophersen Denmark 37 1.2k 0.7× 815 0.6× 1.6k 1.2× 571 1.2× 712 1.8× 157 4.0k
Lester A. Mitscher United States 38 2.4k 1.5× 1.1k 0.8× 2.0k 1.6× 775 1.6× 183 0.5× 170 5.4k
Ken‐ichi Kawai Japan 30 1.3k 0.8× 1.6k 1.1× 1.0k 0.8× 613 1.2× 687 1.8× 228 3.6k
Akira Nakagawa Japan 37 2.3k 1.4× 1.8k 1.3× 1.9k 1.5× 355 0.7× 635 1.6× 151 4.6k
Christoph Tamm Switzerland 28 1.6k 1.0× 744 0.5× 1.2k 0.9× 301 0.6× 306 0.8× 165 3.0k
Sándor Antus Hungary 35 1.4k 0.9× 1.1k 0.8× 1.4k 1.1× 586 1.2× 381 1.0× 190 3.6k
Kenneth M. Snader United States 22 2.7k 1.7× 1.5k 1.1× 1.6k 1.2× 1.3k 2.7× 761 2.0× 42 6.3k

Countries citing papers authored by W. Keller‐Schierlein

Since Specialization
Citations

This map shows the geographic impact of W. Keller‐Schierlein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Keller‐Schierlein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Keller‐Schierlein more than expected).

Fields of papers citing papers by W. Keller‐Schierlein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Keller‐Schierlein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Keller‐Schierlein. The network helps show where W. Keller‐Schierlein may publish in the future.

Co-authorship network of co-authors of W. Keller‐Schierlein

This figure shows the co-authorship network connecting the top 25 collaborators of W. Keller‐Schierlein. A scholar is included among the top collaborators of W. Keller‐Schierlein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Keller‐Schierlein. W. Keller‐Schierlein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hagmann, Leonhard, et al.. (1988). Metabolites of microorganisms. 242. Pyridindolol glucosides from Streptomyces parvulus.. The Journal of Antibiotics. 41(3). 289–295. 7 indexed citations
3.
Keller‐Schierlein, W., et al.. (1984). Stoffwechselprodukte von Mikroorganismen 227. Mitteilung. Isolierung und Strukturaufklärung von Rutamycin B. Helvetica Chimica Acta. 67(5). 1208–1216. 20 indexed citations
4.
Keller‐Schierlein, W.. (1979). Metabolites of microorganisms. 186. The aspochalasins A, B, C, and D. Helvetica Chimica Acta. 62. 1501–1524. 5 indexed citations
5.
Keller‐Schierlein, W. & Ernst Kupfer. (1979). Stoffwechselprodukte von Mikroorganismen. 186. Mitteilung. Über die Aspochalasine A, B, C und D. Helvetica Chimica Acta. 62(5). 1501–1524. 45 indexed citations
6.
Kupfer, Ernst, et al.. (1979). Stoffwechselprodukte von Mikroorganismen. 177. Mitteilung. Avilamycin C. Helvetica Chimica Acta. 62(1). 1–6. 6 indexed citations
7.
Keller‐Schierlein, W., et al.. (1979). ChemInform Abstract: METABOLIC PRODUCTS OF MICROORGANISMS. 178. AVILAMYCINS A AND C: CHEMICAL DECOMPOSITION AND SPECTROSCOPIC STUDIES. Chemischer Informationsdienst. 10(19). 1 indexed citations
8.
Keller‐Schierlein, W., et al.. (1979). ChemInform Abstract: METABOLITES OF MICROORGANISMS. 186. THE ASPOCHALASINS A, B, C, AND D. Chemischer Informationsdienst. 10(43). 1 indexed citations
9.
Goldstein, Alma W., et al.. (1978). Biotransformation of lankamycin, darcanolide, and 11-acetyllankolide by a blocked mutant of the erythromycin producing organism Streptomyces erythreus.. The Journal of Antibiotics. 31(1). 63–69. 3 indexed citations
10.
Martin, Jerry R., et al.. (1977). Minor Lankamycin‐Related Antibiotics from Streptomyces violaceoniger. Helvetica Chimica Acta. 60(8). 2559–2565. 8 indexed citations
11.
Martin, Jerry R., Richard S. Egan, Alma W. Goldstein, et al.. (1976). 3″‐De‐O‐methyl‐2″,3″‐anhydro‐lankamycin, a New Macrolide Antibiotic from Streptomyces violaceoniger. Helvetica Chimica Acta. 59(5). 1886–1894. 14 indexed citations
12.
Keller‐Schierlein, W., et al.. (1973). [Metabolic products of microorganisms. 118. Delta-N-hydroxy-L-arginine, an amino acid antagonist from Nannizzia gypsea].. PubMed. 91(3). 203–20. 4 indexed citations
13.
Keller‐Schierlein, W., et al.. (1970). Stoffwechselprodukte von Mikroorganismen 80. Mitteilung [1] Aranciamycin. Helvetica Chimica Acta. 53(4). 779–789. 22 indexed citations
14.
Balerna, M., W. Keller‐Schierlein, C. Martius, H. Wolf, & H Zähner. (1969). [Metabolic products of microorganisms. 72. Naphthomycin, an antimetabolite of vitamin K].. PubMed. 65(4). 303–17. 9 indexed citations
15.
Gerlach, Hans, Ralf Hütter, W. Keller‐Schierlein, J. Seibl, & Hans Zähner. (1967). Stoffwechselprodukte von Mikroorganismen. 58. Mitteilung [1]. Neue Makrotetrolide aus Actinomyceten. Helvetica Chimica Acta. 50(7). 1782–1793. 22 indexed citations
16.
Brufani, M. & W. Keller‐Schierlein. (1966). 236. Stoffwechselprodukte von Mikroorganismen. 54. Mitteilung [1]. Über die Zuckerbausteine des Angolamycins: L‐Mycarose, D‐Mycinose und D‐Angolosamin. Helvetica Chimica Acta. 49(7). 1962–1970. 18 indexed citations
17.
H�tter, R., et al.. (1965). Stoffwechselprodukte von Mikroorganismen. Archives of Microbiology. 51(1). 1–8. 23 indexed citations
18.
Keller‐Schierlein, W. & V. Prelog. (1961). Stoffwechselprodukte von Actinomyceten. 30. Mitteilung. Über das Ferrioxamin E; ein Beitrag zur Konstitution des Nocardamins. Helvetica Chimica Acta. 44(7). 1981–1985. 35 indexed citations
19.
Keller‐Schierlein, W., et al.. (1959). Stoffwechselprodukte von Actinomyceten. 19. Mitteilung N‐Acetyl‐tyramin. Helvetica Chimica Acta. 42(5). 1730–1732. 7 indexed citations
20.
Corbaz, R., L. Ettlinger, W. Keller‐Schierlein, & H Zähner. (1957). [Systematology of Actinomyces. II. Actinomycin forming Streptomyces].. PubMed. 26(2). 192–208. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by NOBORU OTAKE Breakdown of academic impact, for papers by Petr Sedmera Breakdown of academic impact, for papers by D. Arigoni Breakdown of academic impact, for papers by Carsten Christophersen Breakdown of academic impact, for papers by Lester A. Mitscher Breakdown of academic impact, for papers by Ken‐ichi Kawai Breakdown of academic impact, for papers by Akira Nakagawa Breakdown of academic impact, for papers by Christoph Tamm Breakdown of academic impact, for papers by Sándor Antus Breakdown of academic impact, for papers by Kenneth M. Snader
Rankless by CCL
2026